跳至主要内容
临床试验/ITMCTR2200005625
ITMCTR2200005625已完成未知

A retrospective clinical study on the combination of traditional Chinese and Western medicine in the treatment of limited-disease small cell lung cancer

Guang'anmen Hospital, China Academy of Chinese Medicine Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • (1) The age ranges from 18 to 75 years.
  • (2) Patients with localized SCLC with clear pathological diagnosis, following NCCN clinical guidelines, and receiving standardized treatment such as chest radiotherapy, chemotherapy, or prophylactic brain irradiation.
  • (3) Survival time > 3 months.
  • (4) The integrated Chinese and Western medicine treatment group received TCM treatment =6 months.

排除标准

  • (1) complicated with serious diseases of heart, liver, kidney and hematopoietic system.
  • (2) other types of primary malignancy.
  • (3) pregnant women, mental patients and patients suffering from other malignant tumors.
  • (4) Patients who have participated in clinical trials of new drugs.
  • (5) Absence of basic information.

研究者

发起方
Guang'anmen Hospital, China Academy of Chinese Medicine Sciences

相似试验